Roche is looking to a busy 2026 after 10 new molecules entered late-stage testing last year and as a potential launch of ...
The “Highlights REAL” campaign, which Bayer kicked off Thursday, stars Romo, who played for the Dallas Cowboys before ...
Last year, Novartis debuted its first-ever Super Bowl ad with an aim of starting “a movement” around early breast cancer ...
Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...
Biosynthesis specialist Antheia has topped off its series C funding with a second close, adding $24 million more to its haul.
Consumer advocacy organization Public Citizen has filed (PDF) a Freedom of Information Act (FOIA) lawsuit against the Department of Health and Human Services (HHS) and the Department of Commerce (DOC) ...
Shortly after acquiring Elektrofi to beef up its subcutaneous drug-delivery offerings, Halozyme Therapeutics has struck ...
Even as Johnson & Johnson’s oncology superstar Darzalex Faspro racks up megablockbuster sales and reshapes the multiple ...
But while the rankings held steady, the operating environment has changed quickly to reinforce the value of being in good ...
"Detect the SOS is a multi-stakeholder movement that brings together trusted voices, advocates, healthcare professionals and ...
After posting 16.2% revenue growth in the last financial year, Servier President Olivier Laureau said the company has moved ...
Under CEO Richard Francis’ “Pivot to Growth” strategy, Teva Pharmaceutical Industries has undergone a significant ...